Episode 216: Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma Podcast Por  arte de portada

Episode 216: Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

Episode 216: Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

Escúchala gratis

Ver detalles del espectáculo
Joe Selvaggi talks with Pioneer Institute Director Bill Smith about the Inflation Reduction Act's impact on drug pricing negotiations and its potential effects on drug development, consumers, and taxpayers.
Todavía no hay opiniones